Interleukin Genetics Inc

Type: Company
Name: Interleukin Genetics Inc
First reported Jul 25 2014 - Updated Jul 25 2014 - 2 reports

INTERLEUKIN GENETICS INC FILES (8-K) Disclosing Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. On July 23, 2014, at the 2014 Annual Meeting of Stockholders (the "Annual Meeting") of Interleukin Genetics, Inc. (the "Company"), at ... ... [Published Street Sweeper - Jul 25 2014]
First reported May 14 2014 - Updated May 14 2014 - 3 reports

Interleukin Genetics Reports First Quarter 2014 Financial Results

WALTHAM, Mass.--(EON: Enhanced Online News)--Interleukin Genetics, Inc. (OTCQB:ILIU) today issued financial and operational results for its fiscal first quarter ended March 31, 2014. “We are proud to report the achievement of multiple milestones so far ... [Published EON Business - May 14 2014]
First reported May 07 2014 - Updated May 07 2014 - 1 reports

Interleukin Genetics, Inc. Announces Conference Call to Discuss First Quarter 2014 Results

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) announced today that it will host a conference call and Webcast on Wednesday, May 14, 2014 at 4:30 p.m. (ET) to provide a corporate update and discuss the Company’s first quarter ... [Published Business Wire Health News - May 07 2014]
First reported Apr 22 2014 - Updated Apr 22 2014 - 1 reports

Interleukin Genetics Secures Approval in New York State to Offer PerioPredict™

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) today announced it has received conditional approval from the New York State Department of Health to offer, process and report the results of the PerioPredict™ Genetic Risk Test ... [Published Business Wire Health News - Apr 22 2014]
First reported Apr 11 2014 - Updated Apr 11 2014 - 1 reports

Interleukin Genetics Publishes Additional Evidence for the PerioPredict™ Genetic Risk Test in Journal of Periodontal Research

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) today announced the pre-print online publication of its research study titled “Association of interleukin-1 gene variations with moderate to severe chronic periodontitis in multiple ... [Published Business Wire Health News - Apr 11 2014]
First reported Mar 31 2014 - Updated Apr 01 2014 - 1 reports

Interleukin Genetics Announces Changes to Its Board of Directors

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) today announced several changes to the Company’s Board of Directors. Joseph Landstra, Director of Finance at Alticor Corporate Enterprises, will join the Board as a Director, filling ... [Published Business Wire Health News - Mar 31 2014]
First reported Mar 20 2014 - Updated Mar 20 2014 - 1 reports

Interleukin Genetics Reports Fourth Quarter and Year-End 2013 Financial Results

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) today issued financial and operational results for its fiscal fourth quarter and full fiscal year ended December 31, 2013. “Interleukin Genetics achieved a number of important milestones ... [Published Business Wire Health News - Mar 20 2014]
First reported Mar 13 2014 - Updated Mar 13 2014 - 1 reports

Interleukin Genetics, Inc. Announces Conference Call to Discuss Fourth Quarter 2013 Results

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) announced today that it will host a conference call and Webcast on Thursday, March 20, 2014 at 4:30 p.m. (ET) to provide a corporate update and discuss the Company’s fourth quarter ... [Published Business Wire Health News - Mar 13 2014]
First reported Feb 10 2014 - Updated Feb 10 2014 - 1 reports

DNA-Based Dieting More Than Doubles Weight Loss—BalanceDiet™ Buckhead...

BalanceDiet™ Buckhead of Atlanta, GA, offers a weight management genetic fat test designed to create individualized lifestyle plans based on clients’ DNA—studies show that those who follow a DNA-based diet lose 2.5 times more weight than those who do ... [Published PRWeb - Feb 10 2014]

Quotes

Meeting ") of Interleukin Genetics Inc. (the "Company"), at which a quorum was"

More Content

All (12) | News (3) | Reports (0) | Blogs (9) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
INTERLEUKIN GENETICS INC FILES (8-K) Disclosing... [Published Street Sweeper - Jul 25 2014]
INTERLEUKIN GENETICS : Submission of Matters to... [Published 4 Traders - Jul 25 2014]
Interleukin Genetics Reports First Quarter 2014... [Published EON Business - May 14 2014]
Interleukin Genetics Reports First Quarter 2014... [Published Business Wire Professional Services News - May 14 2014]
Interleukin Genetics Reports First Quarter 2014... [Published Business Wire Health News - May 14 2014]
Interleukin Genetics, Inc. Announces Conference... [Published Business Wire Health News - May 07 2014]
Interleukin Genetics Secures Approval in New Yo... [Published Business Wire Health News - Apr 22 2014]
Interleukin Genetics Publishes Additional Evide... [Published Business Wire Health News - Apr 11 2014]
Interleukin Genetics Announces Changes to Its B... [Published Business Wire Health News - Mar 31 2014]
Interleukin Genetics Reports Fourth Quarter and... [Published Business Wire Health News - Mar 20 2014]
Interleukin Genetics, Inc. Announces Conference... [Published Business Wire Health News - Mar 13 2014]
DNA-Based Dieting More Than Doubles Weight Loss... [Published PRWeb - Feb 10 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Interleukin Genetics Reports First Quarter 2014... [Published EON Business - May 14 2014]
WALTHAM, Mass.--(EON: Enhanced Online News)--Interleukin Genetics, Inc. (OTCQB:ILIU) today issued financial and operational results for its fiscal first quarter ended March 31, 2014. “We are proud to report the achievement of multiple milestones so far ...
Interleukin Genetics Reports First Quarter 2014... [Published Business Wire Professional Services News - May 14 2014]
WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) today issued financial and operational results for its fiscal first quarter ended March 31, 2014. “We are proud to report the achievement of multiple milestones so far in 2014, including ...
Interleukin Genetics Reports First Quarter 2014... [Published Business Wire Health News - May 14 2014]
WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) today issued financial and operational results for its fiscal first quarter ended March 31, 2014. “We are proud to report the achievement of multiple milestones so far in 2014, including ...
Interleukin Genetics, Inc. Announces Conference... [Published Business Wire Health News - May 07 2014]
WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) announced today that it will host a conference call and Webcast on Wednesday, May 14, 2014 at 4:30 p.m. (ET) to provide a corporate update and discuss the Company’s first quarter ...
Interleukin Genetics Secures Approval in New Yo... [Published Business Wire Health News - Apr 22 2014]
WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB:ILIU) today announced it has received conditional approval from the New York State Department of Health to offer, process and report the results of the PerioPredict™ Genetic Risk Test ...
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.